Hyperglycemia-Induced Endothelial Dysfunction: From Classical Pathogenetic Mechanisms to Emerging Insights into ACE2 Protective Action
International Journal of Molecular Sciences · 14.03.2026 · 27 (6) · 2660
DOI: 10.3390/ijms27062660 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.03.2026. Verfasst von Giada Lodi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: Hyperglycemia, Endothelium, Vascular, Angiotensin-Converting Enzyme 2. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Ferrara, Emilia Romagna Region.
Abstract (Originalsprache)
Diabetes is a pivotal risk factor for cardiovascular disease as well as microvascular complications, including retinopathy and nephropathy. Chronic hyperglycemia is a key player in linking diabetes with endothelial dysfunction which, in turn, contributes to cardiovascular disease. Indeed, hyperglycemia acts as a trigger for endothelial dysfunction, promoting a shift in the endothelium from a protective, anti-inflammatory state to a dysfunctional, injury-prone phenotype. A hyperglycemic environment triggers several pathogenetic mechanisms, including alterations in bioenergetics, production of advanced glycation end products, oxidative stress and mitochondrial dysfunction, all contributing to endothelial dysfunction. The activation of these pathophysiological mechanisms by hyperglycemia culminates in reduced nitric oxide production, as well as the induction of oxidative stress and inflammation, all of which are pivotal in impairing endothelial homeostasis and promoting cellular damage. Besides these classical mechanisms, there is growing attention on novel pathogenetic factors linking diabetic hyperglycemia with endothelial dysfunction, such as the ACE2 protein. The latter is emergeing for its potential to counter hyperglycemia-induced cellular damage through its vasoprotective and anti-inflammatory actions, making it a promising therapeutic target for tackling endothelial dysfunction. This review provides an overview of classical as well as emerging mechanisms underpinning the deleterious effects of diabetic hyperglycemia on endothelial dysfunction. In turn, understanding the molecular interconnections between hyperglycemia and endothelial dysfunction is crucial for developing novel strategies to restore endothelial homeostasis and mitigate diabetic vascular complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy.
- Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
- Department of Environmental and Prevention Sciences and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy.
ORCID-Profile: Giada Lodi, Domenico Sergi, Francesca Bompan, Rebecca Voltan, Arianna Romani
Förderung
- University of Ferrara
- Emilia Romagna Region
Zitieren
APA
Lodi, G., Sergi, D., Dipinto, A., Bompan, F., Secchiero, P., Voltan, R., & Romani, A. (2026). Hyperglycemia-Induced Endothelial Dysfunction: From Classical Pathogenetic Mechanisms to Emerging Insights into ACE2 Protective Action. International Journal of Molecular Sciences, 27(6), 2660. https://doi.org/10.3390/ijms27062660
Vancouver
Lodi G, Sergi D, Dipinto A, Bompan F, Secchiero P, Voltan R, et al. Hyperglycemia-Induced Endothelial Dysfunction: From Classical Pathogenetic Mechanisms to Emerging Insights into ACE2 Protective Action. International Journal of Molecular Sciences. 2026;27(6):2660. doi:10.3390/ijms27062660
BibTeX
@article{Lodi2026,
author = {Lodi, Giada and Sergi, Domenico and Dipinto, Anna and Bompan, Francesca and Secchiero, Paola and Voltan, Rebecca and Romani, Arianna},
title = {Hyperglycemia-Induced Endothelial Dysfunction: From Classical Pathogenetic Mechanisms to Emerging Insights into ACE2 Protective Action},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {6},
pages = {2660},
doi = {10.3390/ijms27062660}
}
EUVIMED